AGENUS INC

AGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2009
Revenue $3.3M
Cost of Revenue $0
Gross Profit $3.3M
Gross Margin 100.0%
Operating Expenses
Research & Development $16.9M
SG&A Expense $14.1M
Operating Income $-27.7M
Operating Margin -830.1%
Interest Expense $5.3M
Pretax Income
Income Tax Expense
Net Income $-30.3M
Net Margin -909.2%
EPS (Basic) $-0.04
EPS (Diluted) $-0.04
Shares Outstanding (Basic)
Shares Outstanding (Diluted)
Dividends Per Share
← Newer Page 3 of 3 Older →